Global Cardiac Surgery Market Analysis 2024: Innovative Cardiac Procedures Drive Market Expansion with 5.5% CAGR through 2030
May 14, 2024 07:42 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Cardiac Surgery Market Size, Share & Trends Analysis 2024-2030 MedSuite: Tissue Heart Valve Market, TAVI/TAVR Market, and More" report has...
Insights on the Transcatheter Aortic Valve Implantation (TAVI) Global Market to 2027 - Featuring Abbott Laboratories, Boston Scientific and Bracco Among Others
June 21, 2022 07:58 ET
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Global Transcatheter Aortic Valve Implantation (TAVI) Market (2022-2027) by Procedure, Geography, Competitive Analysis, and the Impact of Covid-19 with...
Global Transcatheter Treatment: Procedures and Heart Valve Market (2020 to 2025) - Featuring Biotronik, Boston Scientific and Bracco Among Others
February 11, 2021 07:38 ET
|
Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Transcatheter Treatment: Procedures and Heart Valve Market" report has been added to ResearchAndMarkets.com's offering. Transcatheter treatment...
Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
September 24, 2019 16:01 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was...
Colibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR
May 14, 2019 10:00 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...
Colibri Heart Valve to Present Patient Follow-up Results from Clinical Feasibility Study of Second-Generation TAVI System at TCT
September 19, 2018 14:12 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , Sept. 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
May 04, 2018 11:09 ET
|
Colibri Heart Valve, LLC
Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the Colibri transcatheter aortic valve implantation...
Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study
March 19, 2018 10:52 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , March 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the first two patients have been successfully...
Colibri Heart Valve Receives ISO 13485 and EN ISO 13485 Certification
March 03, 2017 10:00 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , March 03, 2017 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announced today that it has...
Colibri Heart Valve Enters Agreement with Venus Medtech to Form Joint Venture to Develop Next-Generation Transcatheter Heart Valve Technologies
September 13, 2016 08:00 ET
|
Colibri Heart Valve, LLC
Broomfield, CO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, has entered into definitive...